Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saturn Biomedical Systems was a medical technology company based in San Diego, California, that specialized in the development of innovative spinal implant systems. The company's primary focus was the Saturn Spinal System, a technology designed to provide stabilization and motion preservation for patients suffering from degenerative disc disease and other spinal disorders. In June 2004, Saturn Biomedical Systems was acquired by NuVasive, a prominent player in the spine surgery market, for approximately $5 million in cash and stock. This strategic acquisition allowed NuVasive to integrate Saturn's intellectual property and product designs into its own portfolio of minimally invasive surgical solutions. The technology developed by Saturn contributed to the advancement of lumbar and cervical spine treatments. Today, the legacy of Saturn's innovations exists within the broader product offerings of Globus Medical, which acquired NuVasive in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saturn Biomedical Systems.